Monod Bio Taps AI Protein Design to Build Rapid Point-of-Care Preeclampsia Test
The Seattle biotech company receives a $750,000 Gates Foundation grant to develop a rapid diagnostic using novel protein binders and a luciferase system.
Read MorePosted by CLP Edit Staff | Oct 15, 2025 | POC Rapid Assays |
The Seattle biotech company receives a $750,000 Gates Foundation grant to develop a rapid diagnostic using novel protein binders and a luciferase system.
Read MorePosted by CLP Edit Staff | Oct 15, 2025 | Melanoma |
New skin tissue analysis tools aim to address diagnostic challenges in one of pathology’s most diverse specialties.
Read MorePosted by CLP Edit Staff | Oct 14, 2025 | Biochemicals & Chemical Reagents |
New TheraPEAK products include mammalian-derived cytokines for immune cell expansion and chemically defined medium for AAV production.
Read MorePosted by CLP Edit Staff | Oct 14, 2025 | Controls |
The quality control product now includes eight opioid drugs or drug metabolites at concentrations above and below assay cutoffs.
Read MorePosted by CLP Edit Staff | Oct 10, 2025 | Molecular Diagnostic Analyzers |
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
Read More